Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

GST Council likely to exempt IGST on cancer drug Dinutuximab import

Ruchika Sharma7 July 2023 2:30 PM IST

Import of cancer medicine Dinutuximab (Qarziba) by individuals for personal use attract a 12 percent IGST.

USFDA grants traditional approval for Eisai Leqembi for Alzheimer's disease treatment

Ruchika Sharma7 July 2023 1:30 PM IST

Stockholm:BioArctic AB's (publ)partner Eisai has announced that the U.S. Food and Drug Administration, FDA, has approved the supplemental Biologics...

Pfizer discontinues development of danuglipron for chronic weight management

Pfizer invests over Rs 206 crore to buy minority stake in Caribou Biosciences

Ruchika Sharma7 July 2023 12:30 PM IST

Caribou said on Thursday it would use the proceeds from Pfizer's investment to advance its experimental CAR-T cell therapy, CB-011, that is currently...

Cipla US unit recalls 6 batches of Albuterol sulfate inhalation aerosol over container defect

Ruchika Sharma7 July 2023 11:26 AM IST

Cipla said there were no adverse events reported for the inhaler related to the recall.

USFDA rejects Amneal Pharma Parkinson's drug over safety concerns

Ruchika Sharma6 July 2023 4:30 PM IST

The agency has not identified efficacy or manufacturing issues with the treatment.

Abbotts Phensedyl Supply Chain Under Scanner After Ghaziabad Seizure, Codeine Diversion Probe Widens

Abbott gets USFDA nod for dual chamber leadless pacemaker

Ruchika Sharma6 July 2023 3:30 PM IST

AVEIR DR leadless pacing system is made up of two devices - the previously-approved AVEIR VR single chamber device, which paces the right ventricle,...

Janssen-Cilag Guselkumab receives UK nod for Crohns disease, ulcerative colitis

Janssen reports positive results from phase 2b FRONTIER 1 trial of JNJ-2113 in plaque psoriasis patients

Ruchika Sharma6 July 2023 2:30 PM IST

JNJ-2113 is a novel oral IL-23R antagonist peptide that binds with high affinity to the IL-23R and has properties that allow it to be absorbed with...

Cancer MedTech Gets Clarity: CDSCO Releases Final Oncology Device Risk Classification List

Medical devices of all four categories will be brought under regulation by October 1: DCGI

Ruchika Sharma6 July 2023 1:30 PM IST

New Delhi: Medical devices of all four categories (A, B, C, and D) will be brought under the regulation by October 1 and as of now only two groups (A...

Setback for Moderna: USFDA Halts Norovirus Vaccine Trial After Guillain-Barre Syndrome Case

Moderna announces global regulatory submissions for respiratory syncytial virus vaccine

Ruchika Sharma6 July 2023 12:30 PM IST

mRNA-1345 is an investigational RSV vaccine that consists of a single mRNA sequence encoding for a stabilized prefusion F glycoprotein.

Biocon unveils Liraglutide for diabetes, obesity in Netherlands

Biocon Biologics takes over biosimilars business from Viatris in over 70 countries

Ruchika Sharma6 July 2023 11:36 AM IST

Dr Reddys Labs inks pact with Henlius for commercialization of multiple myeloma injection HLX15 in US, Europe

Dr Reddys Labs step down arm to establish bio-manufacturing facility in Hyderabad

Ruchika Sharma5 July 2023 3:30 PM IST

The company envisions significant scaling-up their investments in the future, which would result in a multi-fold increase in employment prospects in...

Mankind Pharma Secures Interim Injunction Against Biodiscovery Over Fendikind, Zenkind, Kind Trademarks

Mankind Pharma success boosts hopes of more consumer IPOs in India

Ruchika Sharma5 July 2023 2:30 PM IST

New Delhi: The stellar performance of Mankind Pharma Ltd. since its listing in Mumbai in May could trigger more consumer-related initial public...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok